What does medcomms mean, and what do medical communications agencies do?

Medcomms vs pharma advertising

Medcomms and pharma advertising both communicate about products, but their purpose, audience and rules differ.

What medical communications agencies do

• Publication planning and writing. Plan which data from trials and real-world studies should be published, where and when, then help authors write manuscripts, abstracts and posters in line with good publication practice and journal rules.
• Medical education. Develop content for CMEs, webinars, symposia and e-learning modules for doctors and pharmacists.
• Advisory boards and expert meetings. Prepare briefing material, run the meeting logistics and write up insights for the medical team.
• Key opinion leader programmes. Support engagement with specialists who contribute to education and research, within transparent and compliant arrangements.
• Scientific platforms and narratives. Build the core evidence story for a therapy area that every other communication draws from.
• Congress support. Produce symposium content, booth material and scientific posters for medical conferences.
• Medical science liaison support. Create training modules and response documents for field medical teams.
• Digital HCP engagement. Run educational content programmes on email, webinars, professional networks and HCP portals.
• Patient education. Write accurate, non-promotional disease information, usually distributed through doctors.

How medcomms works in India

Indian medcomms sits inside a clear regulatory frame:

• UCPMP 2024. The Department of Pharmaceuticals' code sets rules for claims, promotional material, CMEs, sponsorship and interactions with doctors. Claims must be balanced, up to date and backed by evidence. Our explainer on UCPMP 2024 covers the main provisions.
• Drugs and Cosmetics Act and Rules. Prescription drugs may be promoted only to registered medical practitioners and other healthcare professionals, not to the public.
• Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Bars claims that a drug cures or prevents listed diseases.
• NMC guidelines for doctors. Doctors who take part in education programmes must follow their own professional conduct rules on gifts, travel and endorsements.
• DPDP Act, 2023. Doctor contact databases used for digital engagement are personal data and need a lawful basis.

This page explains common practice, not legal advice. Pharma teams should run all material through their medical, legal and regulatory review process.

How a typical medcomms project runs

Most projects follow the same sequence. The medical team sets the objective, such as preparing doctors for a new indication or publishing a trial's secondary results. The agency reviews the source data and literature, then drafts a content plan with key messages tied to evidence. Writers produce the first drafts, which go through internal scientific review and quality control of every reference. The client's medical, legal and regulatory reviewers then approve, request changes or reject claims. Only approved material is used, and each version is logged so the company can show what was said, to whom and on what evidence. This audit trail is as important as the content itself, especially when a regulator or complaint panel asks questions later.

Who uses medcomms agencies

Multinational and Indian pharma companies use medcomms support for launches, life-cycle management and therapy-area leadership. Medical device and diagnostics companies use it to educate surgeons and lab specialists on new technologies. Smaller companies often use an agency because they lack an in-house medical writing team, while larger companies use agencies to add capacity around launches and congresses.

What to look for in a medcomms partner

• Therapy-area experience. Writers who understand oncology, diabetes or cardiology evidence produce accurate first drafts faster.
• Medically qualified writers and reviewers. Pharmacology, life-sciences or medical backgrounds, with a separate review step.
• Referencing discipline. Every claim linked to a source, with references checked against the original paper.
• Compliance awareness. Familiarity with UCPMP 2024 and your internal SOPs, so material passes review with fewer cycles.
• Confidentiality and data handling. Clear NDAs and secure handling of unpublished data.

Our guide to pharma KOL content workflows shows how expert input flows into compliant content, and how to write UCPMP-clean pharma content covers claim wording. If you are weighing an outside partner for documents, read about outsourcing medical writing in India.

Medcomms and digital HCP engagement

Doctors in India increasingly consume medical education online, through webinars, professional networks, email and short-form video. Medcomms teams now plan content for these channels alongside traditional print and congress material. The principles stay the same: accurate science, balanced claims, clear disclosure of sponsorship and respect for the doctor's time. See our view on HCP engagement in India.

Detailed answers